Nous sommes auteurs et co-auteurs de nombreuses publications dans des revues médicales et scientifiques à comité de lecture, consultables en ligne sur notre site.
050
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia.
Elalamy I, Tardy-Poncet B, Mulot A, de Maistre E, Pouplard C, Nguyen P, Cleret B, Gruel Y, Lecompte T, Tardy B; GEHT HIT Study Group. Collaborators (17)
Blanloeil Y, de Maistre E, Mulot A, Nguyen P, Pouplard C, Cleret B, Elalamy I, Gruel Y, Lecompte T, Tardy B, Tardy-Poncet B, Clerson P, Lecrubier C, Reynaud J, Sidaner I, Szymezak J, Trossaert M.
049
[Multifactorial and typological analysis of frailty in uncontrolled hypertensives. The Eclat survey.] [Article in French]
Ducluzeau PH, Benetos A, Pannier B, Covillard J, Naudascher M, Geneix-Benabdallah F, Clerson P, Prost PL. Endocrino-diabétologie-nutrition, CHU Hôtel-Dieu, 4, rue Larrey, 49030 Angers cedex, France.
048
Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial.
Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazières B, Maugars Y, Mulleman D, Clerson P, Chevalier X. Hôpital Lariboisière, Assistance Publique Hôpitaux de Paris, Paris, France.
047
Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study.
Hachulla E, Carpentier P, Gressin V, Diot E, Allanore Y, Sibilia J, Launay D, Mouthon L, Jego P, Cabane J, de Groote P, Chabrol A, Lazareth I, Guillevin L, Clerson P, Humbert M; the ItinérAIR-Sclérodermie Study Investigators. Internal Medicine, Hôpital Claude Huriez, Lille, Vascular Medicine, Hôpital Nord, Grenoble, Actelion Pharmaceuticals France, Paris, Internal Medicine, Hôpital Bretonneau, Tours, Rheumatology, Hôpital Cochin, Paris, Rheumatology, Hôpital de Hautepierre, Strasbourg, Internal Medicine, Hôpital Cochin, Paris, Internal Medicine, Hôpital Sud, Rennes, Internal Medicine, Hôpital Saint Antoine, Paris, Cardiology, Hôpital Cardiologique, Lille, Internal Medicine, Pavillon des Médecines, Hôpital de Toulouse-Purpan, Toulouse, Service de Médecine Vasculaire, Groupe Hospitalier Saint-Joseph, Paris, Orgamétrie, Roubaix and Université Paris-Sud 11, Respiratory, Hôpital Antoine Béclère, Assistance Publique Hôpitaux de Paris, Clamart, France.
046
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme.
de Groote P, Isnard R, Clerson P, Jondeau G, Galinier M, Assyag P, Demil N, Ducardonnet A, Thebaut JF, Komajda M. Pôle de Cardiologie et Maladies Vasculaires, CHRU de Lille, Université de Lille 2, France.
045
Masked hypertension: a systematic review.
Bobrie Ga, Clerson Pb, Ménard Jc, Postel-Vinay Na, Chatellier Gc, Plouin PFa,c. aHypertension Department, European Georges Pompidou Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France bOrgamétrie, Roubaix, France cParis Descartes University, France.
044
Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey.
de Groote P, Isnard R, Assyag P, Clerson P, Ducardonnet A, Galinier M, Jondeau G, Leurs I, Thébaut JF & Al Service de Cardiologie C, Hôpital Cardiologique, CHRU, Bd du Pr Jules Leclercq, 59037 Lille Cedex, France.
043
Natural History of Ischemic Digital Ulcers in Systemic Sclerosis: Single-Center Retrospective Longitudinal Study.
Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY. From the Department of Internal Medicine, National Reference Center for Scleroderma, Claude Huriez Hospital, University of Lille, Lille; and Orgamétrie Biostatistiques, Roubaix, France.
042
Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era.
Sitbon O, Lascoux-Combe C, Delfraissy JF, Yeni PG, Raffi F, De Zuttere D, Gressin V, Clerson P, Sereni D, Simonneau G. Service de Pneumologie et Reanimation, Hopital Antoine Beclere, Clamart, France.
041
First-intent monotherapy: persistence rate of antihypertensive treatment is better with angiotensin receptor blockers. Ol'métrise Cardio survey results
Poncelet P, Clerson P, Koch C, Mahmoudi A, Mosnier M., Polyclinique de Hénin-Beaumont - Route de Courrières - Hénin Beaumont.